Predictive value of BRCA1, ERCC1, ATP7B, PKM2, TOPOI, TOPΟ-IIA, TOPOIIB and C-MYC genes in patients with small cell lung cancer (SCLC) who received first line therapy with cisplatin and etoposide. [electronic resource]
Producer: 20140616Description: e74611 p. digitalISSN:- 1932-6203
- Adenosine Triphosphatases -- genetics
- Adult
- Aged
- Antigens, Neoplasm -- genetics
- BRCA1 Protein -- genetics
- Carrier Proteins -- genetics
- Cation Transport Proteins -- genetics
- Cisplatin -- pharmacology
- Copper-Transporting ATPases
- DNA Topoisomerases, Type I -- genetics
- DNA Topoisomerases, Type II -- genetics
- DNA-Binding Proteins -- genetics
- Disease-Free Survival
- Endonucleases -- genetics
- Etoposide -- pharmacology
- Gene Expression Regulation, Neoplastic -- drug effects
- Genes, Neoplasm -- genetics
- Genes, myc
- Humans
- Lung Neoplasms -- drug therapy
- Membrane Proteins -- genetics
- Middle Aged
- Multivariate Analysis
- Predictive Value of Tests
- RNA, Messenger -- genetics
- Small Cell Lung Carcinoma -- drug therapy
- Thyroid Hormones -- genetics
- Treatment Outcome
- Thyroid Hormone-Binding Proteins
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.